Electrical stimulation of the carotid sinus for the treatment of resistant hypertension

Current Hypertension Reports

Volumn 8, Issue 5, 2006, Pages 420-424

  Filippone, J D ^b   Sloand, James A ^b   Illig, Karl A ^b   Bisognano, John D ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE REGULATION; CAROTID SINUS; CAROTID SINUS PRESSORECEPTOR REFLEX; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ELECTROSTIMULATION; FEASIBILITY STUDY; HUMAN; HYPERTENSION; IMPLANT; MEAN ARTERIAL PRESSURE; MEDICAL INSTRUMENTATION; MORBIDITY; MORTALITY; NONHUMAN; PATIENT COMPLIANCE; PATIENT SAFETY; REVIEW; SYMPATHETIC TONE; THERAPY RESISTANCE; TREATMENT FAILURE;

BAROREFLEX; CAROTID SINUS; DRUG RESISTANCE; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; HUMANS; HYPERTENSION; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 33749069324     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0089-5     Document Type: Review

References (47)

1. American Heart Association, http://www.americanheart.org/ presenter.jhtml?identifier=4621 Hypertension Statistics. Accessed July 21, 2006.
2. Spranger C, Ries AJ, Berge CA, et al.: Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 2004, 117:14-18.
3. Berlowitz D, Ash AS, Hickey EC, et al.: Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998, 339:1957-1963.
4. McFarlane SI, Castro J, Kaur J, et al.: Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men. J Clin Hypertens 2005, 7:73-80.
5. Hajja r I, Kotchen TA: Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
6. Cushman WC, Ford CE, Cutler JA, et al.: Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2003:4:393-404.
7. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001:358:1305-1315.
8. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003, 21:1055-1076.
9. Lampen H, Kezdi P, Koppermann E, et al.: Experimenteller entzugelungshochdruck bei arterieller hypertonie. Z Kreislaufforschung 1949, 38:577-592.
10. Carlsten A, Folkow B, Grimby G, et al.: Cardiovascular effects of direct simulation of the carotid sinus nerve in man. Acta Physiol Scanda 1958, 44:138-145.
11. Bisognano J, Sloand J, Papademetriou V, et al.: Baroreflex hypertension therapy with a chronically implanted system: early results from the Rheos feasibility trial in patients with resistant hypertension. J Clin Hypertension 2006, 8(Supp A):850
12. Esler M: The sympathetic system and hypertension. Am J Hypertens 2000, 13:99S-105S.
13. Esler M, Rumantir M, Wiesner G, et al.: Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertension 2001, 14:304S-309S.
14. Grassi G, Esler M: The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player? J Hypertens 2002, 20:1071-1073.
15. Anderson EA, Sinkey CA, Lawton WJ, Mark AL: Elevated sympathetic nerve activity in borderline hypertensive humans-evidence from direct intraneural recordings. Hypertension 1989, 14:177-183.
16. Lohmeier TE: The sympathetic nervous system and longterm blood pressure regulation. Am J Hypertens 2001, 14:147S-154S.
17. Ferrier C, Cox H, Esler M: Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci 1993, 84:225-230.
18. Braunwald E: Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 2001:2173.
19. Chapleau M: Arterial Baroreflexes. In Hypertension Primer Second Edition, The Essentials of High Blood Pressure. Edited by Council on High Blood Pressure Research, American Heart Association. Hagerstown, MD: Lippincott Williams & Wilkins; 1999:83.
20. Timmers HJML, Wieling W, Karemaker JM, Lenders JWM: Baroreflex failure: a neglected type of secondary hypertension, Neth J Med 2004, 62:151-155.
21. Rooke T, Sparks H: Control mechanisms in circulatory function. In Medical Physiology, edn 2. Edited by Rhoades RA, Tanner GA. Baltimore, MD: Lippincot Williams & Wilkins; 290-303.
22. Neistadt A, Schwartz S: Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension. Surgery 1967, 61:923-931.
23. Rodney LJ: Cardiovascular receptor reflexes and central control. In An Introduction to Cardiovascular Physiology, edn 4. Edited by Levick JR. London: Hodder Arnold; 2003:279-296.
24. Mohrman DE, Heller LJ: Cardiovascular Physiology, edn 4. New York: McGraw-Hill; 2003:151-158
25. Lohmeier TE, Hildebrandt DA, Warren S, et al.: Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol 2005, 288:R828-R836.
26. McCubbin JW, Green JH, Page IH: Baroreceptor function in chronic renal hypertension. Circ Res 1956, 4:205-210.
27. Malpas SC: What sets the long-term level of sympathetic nerve activity: Is there a role for aterial baroreceptors? Am J Physiol Regul Integr Comp Physiol 2004, 286:R1-R12.
28. Bristow JD, Honour AJ, Pickering GW, et al.: Diminished baroreflex sensitivity in high blood pressure. Circulation 1969, 39:48-54.
29. Lohmeier TE: The sympathetic nervous system and longterm blood pressure regulation. Am J Hypertens 2001, 14:147S-154S.
30. Warner HR: The frequency-dependent nature of blood pressure regulation by the carotid sinus studied with an electrical analog. Circ Res 1958, 6:35-40.
31. Bilgutay A, Lillehei W: Treatment of hypertension with an implantable electronic device. JAMA 1965, 191:113-117.
32. Bilgutay A, Lillehei W: Surgical treatment of hypertension with reference to baropacing. Am J Cardiol 1966, 17:663-667.
33. Schwartz S, Griffith L, Neistadt A, Hagfors N: Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg 1967, 114:5-15.
34. Neufeld H, Goor D, Nathan D, et al.: Stimulation of the carotid baroreceptors using a radiofrequency method. Isralei J Med Sci 1965, 1:630-632.
35. Braunwald E, Epstein S, Glick G, et al.: Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med 1967, 277:1278-1283.
36. Tuckman J, Reich T, Lyon A, et al.: Electrical stimulation of the sinus nerves in hypertensive patients-clinical evaluation and physiological studies. Hypertension 1967, 194S:23-38.
37. Peters T, Koralewski H, Zerbst E: Search for optimal frequencies and amplitudes of therapeutic electrical carotid sinus nerve stimulation by application of the evolutionary strategy. Artif Organs 1989, 13:133-143
38. Peters T, Koralewski H, Zerbst E: The principle of electrical carotid sinus nerve stimulation: a nerve pacemaker system for angina pectoris and hypetension therapy. Ann Biomed Eng 1980, 8:445-458.
39. Wallin BG, Sundlof G, Delius W: The effect of carotid sinus nerve stimulation on muscle and skin nerve sympathetic activity in man. Pflugers Arch 1975, 358:101-110.
40. Ferrier C, Cox H, Esler M: Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci 1993, 84:225-230.
41. Mancia G, Grassi G, Giannattasio C, Servalle G: Sympathetic activation in the pathogenesis of hypertension and progressive organ damage. Hypertension 1999, 34:724-728.
42. Lohmeier TE, Lohmeier JR, Warren S, et al.: Sustained activation of the central baroreceptor pathway in angiotensin hypertension. Hypertension 2002, 39:550-556.
43. Lohmeier TE, Lohmeier JR, Haque A, Hilderbrandt DA: Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension. Am J Phsiol Regul Integr Comp Physiol 2000, 279:R1437-R1448.
44. Lohmeier TE, Hildebrandt DA, Warren S, et al.: Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol 2005, 288:R828-R836.
45. Lohmeier T, Irwin E, Rossing M, et al.: Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 2004, 43:306-311.
46. Lohmeier TE, Dwyer TM, Jackson MS, et al.: Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 2005, 46:816.
47. Lohmeier TE, Dwyer TM, Hildebrandt DA, et al.: Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension 2005, 46:1194-1200.